Home/Pipeline/SOPHiA DDM™ Dx RNAtarget Oncology Solution

SOPHiA DDM™ Dx RNAtarget Oncology Solution

Gene Fusions & Expression in Cancer

CommercialCE-IVD Marked

Key Facts

Indication
Gene Fusions & Expression in Cancer
Phase
Commercial
Status
CE-IVD Marked
Company

About SOPHiA GENETICS

SOPHiA GENETICS is a Swiss health tech company on a mission to democratize data-driven medicine globally through its AI-powered, cloud-native SOPHiA DDM™ platform. The company has achieved significant scale, having analyzed over 2.3 million genomic profiles and serving more than 990 healthcare institutions across 75+ countries. Its strategy centers on expanding its platform's capabilities from genomics into radiomics and multimodal data analysis, while deepening its network effects within the clinical and biopharma ecosystems to drive adoption and insights.

View full company profile